The tech-broification of American science has officially begun

The Trump administration has begun distributing the first tranche of its "Genesis Mission" grants, steering roughly $5 billion toward hundreds of AI-driven science projects. The framing is deliberately grand: the White House has compared the effort to the Manhattan Project, while the administration's science adviser, Michael Kratsios, has taken to Capitol Hill pitching a "New Golden Age" built around artificial intelligence, robotics, and nuclear energy, with life sciences pushed to the margins.

The political logic is straightforward. Washington is consolidating its research dollars around a narrow set of fields that align with the administration's industrial and geopolitical priorities. AI and robotics serve the narrative of technological competition with China; nuclear energy fits the push for expanded domestic power generation. Life sciences, by contrast, carry associations with pandemic-era regulation and politically charged health debates, making them a less attractive vehicle for the administration's messaging.

The funding mechanism matters as much as the totals. By routing the money through a mission-oriented program rather than traditional peer-reviewed channels, the administration gains tighter control over which institutions and which research agendas benefit. The result is a science policy that increasingly resembles a venture capital portfolio: concentrated bets, chosen centrally, justified by strategic narrative rather than by the dispersed judgment of the scientific community.

For universities and research labs, the calculus is shifting. Grants tied to AI infrastructure, large-scale compute, and applied robotics are likely to flow to institutions that can absorb them quickly and demonstrate visible deliverables. Smaller programs in biology, public health, and the social sciences face a quieter squeeze, not through explicit cuts but through the gravitational pull of where the new money is going.

The broader signal is that American science funding is being repurposed as an instrument of industrial policy. The "tech-broification" framing captures something real: a research agenda increasingly shaped by the preferences of a small cohort of technologists and political operators, with the rest of the scientific enterprise expected to align or compete for whatever remains.